Moderna (MRNA) Trade Update: Is the Bottom Finally In?
In my previous post, “Beat SPX in 2025 by 100%: Long-Term MRNA Trade”, I highlighted how Moderna (MRNA) was showing early signs of a potential trend reversal after an 81% decline from its May 2024 peak. While short-term volatility remains, the stock is setting up for a major move, with potential 26% gains in just three months and 100% upside within a year. But what about the bigger picture? Looking … Read more